Search Results - "Nalli, Giulio"

Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors by Garuti, Giancarlo, Cellani, Fulvia, Centinaio, Giovanna, Montanari, Giuseppe, Nalli, Giulio, Luerti, Massimo

“…A prospective evaluation of the effects on endometrium of third generation aromatase inhibitors (AIs), administered as adjuvant up-front therapy or switched…”
Get full text

Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer by Garuti, Giancarlo, Grossi, Francesco, Centinaio, Giovanna, Sita, Giulia, Nalli, Giulio, Luerti, Massimo

“…Abstract Objectives To estimate the pretreatment incidence of endometrial pathology and to prospectively assess the endometrial morbidity emerging during…”
Get full text

Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer by Garuti, Giancarlo, Cellani, Fulvia, Centinaio, Giovanna, Sita, Giulia, Nalli, Giulio, Luerti, Massimo

“…The purpose of the present study is to prospectively evaluate the effects of tamoxifen on the pathological behavior of endometrial hyperplasias without atypia,…”
Get full text

Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women by Garuti, Giancarlo, Cellani, Fulvia, Centinaio, Giovanna, Sita, Giulia, Nalli, Giulio, Luerti, Massimo

“…The aim of this study is to estimate the prevalence of endometrial pathology before the start of tamoxifen therapy in menopausal breast cancer patients…”
Get full text

High prevalence of a screening-detected, HFE-unrelated, mild idiopathic iron overload in Northern Italy by Barosi, G, Salvaneschi, L, Grasso, M, Martinetti, M, Marchetti, M, Bodini, U, Reggiani, A, D'Agostino, F, Nalli, G, Degiuli, A, De Silvestri, A, Arbustini, E

“…Laboratorio di Informatica Medica, IRCCS Policlinico S. Matteo, p.le Golgi 3, 27100 Pavia, Italy. barosig@smatteo.pv.it BACKGROUND AND OBJECTIVES: In Italy,…”
Get full text

Subcutaneous Erythropoietin for Treatment of Refractory Anemia in Hematologic Disorders. Results of a Phase I/II Clinical Trial by Cazzola, Mario, Ponchio, Luisa, Beguin, Yves, Rosti, Vittorio, Bergamaschi, Gaetano, Liberato, Nicola L., Fregoni, Vittorio, Nalli, Giulio, Barosi, Giovanni, Ascari, Edoardo

“…We have used recombinant human erythropoietin (rHuEPO) in a phase I/II clinical trial to evaluate its ability to reverse refractory anemia in hematologic…”
Get full text

Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers by Bergamaschi, G, Stella, C C, Cattoretti, G, Invernizzi, R, Maserati, E, Nalli, G, Pedrazzoli, P, Peverali, F A, Della Valle, G, Ascari, E

“…We describe a novel continuous B-cell line (PV-90) derived from a patient with myelodysplastic syndrome (MDS) and originating from spontaneous infection with…”
Get more information

Fibrinolysis induced by danazol by Rizzo, S C, Grignani, G, Gamba, G, Nalli, G

Get full text

Meningeal leukemia following lymphoid blast crisis in chronic myeloid leukemia: therapeutic implications by Cazzola, M, Nalli, G, Brusamolino, E, Daccò, M, Ghizzi, A, Molinari, E, Tagliabue, A

“…Five of 40 patients with chronic myeloid leukemia (CML) had lymphoid blast crisis and 4 of them achieved complete remission of metamorphosis with vincristine…”
Get more information